Results
1 -
6 of
6Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors, Investigational New Drugs The Biology and Clinical Development of MEK Inhibitors for Cancer, Drugs RG-7167/selumetinib/trametinib, Reactions Weekly MEK and the inhibitors: from bench to bedside, Journal of Hematology & Oncology Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [18F] FDG-PET imaging combined with proteomic approaches, EJNMMI Research